PT  - JOURNAL ARTICLE
AU  - Richterman, Aaron
AU  - Thirumurthy, Harsha
TI  - Cash Transfer Programs and HIV-Related Outcomes: an Analysis of 42 Countries from 1996 to 2019
AID  - 10.1101/2021.12.16.21267921
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.16.21267921
4099  - http://medrxiv.org/content/early/2021/12/17/2021.12.16.21267921.short
4100  - http://medrxiv.org/content/early/2021/12/17/2021.12.16.21267921.full
AB  - Background Many low- and middle-income countries have introduced cash transfer programs as part of their poverty reduction and social protection strategies. These programs have the potential to overcome various drivers of HIV risk behaviors and usage of HIV services, but their overall effects on a broad range of HIV-related outcomes remains unknown.Methods We used publicly reported data to determine whether low- and middle-income countries with HIV prevalence >1% and baseline annual incidence >1/1000 had conditional or unconditional cash transfer programs that covered >5% of the impoverished population, and the year in which those programs began and ended. We obtained country- and individual-level data on HIV-related outcomes from UNAIDS and population-representative household surveys, focusing on the period between 1996 and 2019. We conducted difference-in-differences analyses with country and year fixed effects to evaluate the effects of cash transfer programs on country- and individual-level HIV-related outcomes.Findings Forty-two countries across three continents were included. Among these, 21 were in the intervention group, having implemented cash program(s) with impoverished population coverage greater than 5% during the study period. Cash transfer programs were associated with lower probability of reporting sexually transmitted infection within the last 12 months among females (odds ratio [OR] 0.67, 95% confidence interval [CI] 0.50-0.91) and higher probability of an HIV test within the last 12 months among females (OR 2.61, 95% CI 1.15-5.88) and males (OR 3.19, 95% CI 2.45-4.15). For country-level outcomes, cash transfer programs were associated with a reduction in new HIV infections (incidence rate ratio [IRR] 0.94, 95% CI 0.89-0.99), but not with the proportion of people with HIV receiving antiretroviral therapy (5.0%, 95% CI -0.2-10.1) or AIDS-related deaths (IRR 0.99, 95% CI 0.95-1.03), though temporal analyses showed delayed improvements in both antiretroviral coverage and deaths.Interpretations Cash transfer programs, which are being expanded in the context of the COVID-19 pandemic, have the potential to promote ongoing efforts to end HIV as a public health threat. Alongside the already existing focus on expanding biomedical services, these anti-poverty programs can play a greater role in achieving global targets for HIV prevention and treatment.Funding NoneCompeting Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Analyzed data can be requested from the DHS program website (https://www.dhsprogram.com/Data/) or are publicly available from UNAIDS (http://aidsinfo.unaids.org/), The World Bank (https://data.worldbank.org/data-catalog/), PEPFAR (https://data.pepfar.gov/financial), and The Global Fund (https://data-service.theglobalfund.org/downloads).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAnalyzed data can be requested from the DHS program website (https://www.dhsprogram.com/Data/) or are publicly available from UNAIDS (http://aidsinfo.unaids.org/), The World Bank (https://data.worldbank.org/data-catalog/), PEPFAR (https://data.pepfar.gov/financial), and The Global Fund (https://data-service.theglobalfund.org/downloads).CCTConditional cash transferCIConfidence IntervalDHSDemographic and Health SurveyIRRincidence rate ratioLMIClow- and middle-income countriesORodds ratioPEPFARPresident’s Emergency Plan for AIDS ReliefUCTunconditional cash transferUNAIDSThe Joint United Nations Programme on HIV/AIDS